Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
EPAC vs SWK vs KMT vs SNA vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Tools & Accessories
Manufacturing - Tools & Accessories
Manufacturing - Tools & Accessories
Industrial - Machinery
EPAC vs SWK vs KMT vs SNA vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Manufacturing - Tools & Accessories | Manufacturing - Tools & Accessories | Manufacturing - Tools & Accessories | Industrial - Machinery |
| Market Cap | $1.87B | $12.60B | $2.75B | $19.47B | $79.14B |
| Revenue (TTM) | $616M | $15.23B | $2.14B | $5.12B | $18.32B |
| Net Income (TTM) | $90M | $371M | $137M | $1.02B | $2.44B |
| Gross Margin | 49.8% | 30.0% | 31.8% | 51.3% | 52.7% |
| Operating Margin | 21.2% | 7.8% | 9.6% | 24.7% | 19.8% |
| Forward P/E | 18.7x | 17.8x | 11.2x | 19.6x | 21.7x |
| Total Debt | $228M | $5.86B | $643M | $1.33B | $13.76B |
| Cash & Equiv. | $152M | $280M | $141M | $1.62B | $1.54B |
EPAC vs SWK vs KMT vs SNA vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Enerpac Tool Group … (EPAC) | 100 | 198.4 | +98.4% |
| Stanley Black & Dec… (SWK) | 100 | 64.6 | -35.4% |
| Kennametal Inc. (KMT) | 100 | 130.1 | +30.1% |
| Snap-on Incorporated (SNA) | 100 | 288.4 | +188.4% |
| Emerson Electric Co. (EMR) | 100 | 231.5 | +131.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EPAC vs SWK vs KMT vs SNA vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EPAC is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 4.6%, EPS growth 9.0%, 3Y rev CAGR 2.6%
- PEG 0.11 vs EMR's 4.80
- 4.6% revenue growth vs KMT's -3.9%
- Lower P/E (18.7x vs 21.7x), PEG 0.11 vs 4.80
SWK ranks third and is worth considering specifically for dividends.
- 4.1% yield, 16-year raise streak, vs EMR's 1.5%
KMT is the clearest fit if your priority is momentum.
- +77.9% vs EPAC's -17.7%
SNA carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 16 yrs, beta 0.76, yield 2.3%
- Lower volatility, beta 0.76, Low D/E 22.3%, current ratio 4.79x
- Beta 0.76, yield 2.3%, current ratio 4.79x
- 20.0% margin vs SWK's 2.4%
EMR is the clearest fit if your priority is long-term compounding.
- 207.0% 10Y total return vs SNA's 168.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.6% revenue growth vs KMT's -3.9% | |
| Value | Lower P/E (18.7x vs 21.7x), PEG 0.11 vs 4.80 | |
| Quality / Margins | 20.0% margin vs SWK's 2.4% | |
| Stability / Safety | Beta 0.76 vs SWK's 1.83, lower leverage | |
| Dividends | 4.1% yield, 16-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +77.9% vs EPAC's -17.7% | |
| Efficiency (ROA) | 12.2% ROA vs SWK's 1.7%, ROIC 18.1% vs 5.8% |
EPAC vs SWK vs KMT vs SNA vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EPAC vs SWK vs KMT vs SNA vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SNA leads in 2 of 6 categories
SWK leads 1 • EMR leads 1 • EPAC leads 0 • KMT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SNA leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 29.7x EPAC's $616M. SNA is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to SWK's 2.4%. On growth, KMT holds the edge at +21.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $616M | $15.2B | $2.1B | $5.1B | $18.3B |
| EBITDAEarnings before interest/tax | $147M | $1.7B | $275M | $1.4B | $4.7B |
| Net IncomeAfter-tax profit | $90M | $371M | $137M | $1.0B | $2.4B |
| Free Cash FlowCash after capex | $102M | $726M | $73M | $1.1B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +49.8% | +30.0% | +31.8% | +51.3% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +21.2% | +7.8% | +9.6% | +24.7% | +19.8% |
| Net MarginNet income ÷ Revenue | +14.6% | +2.4% | +6.4% | +20.0% | +13.3% |
| FCF MarginFCF ÷ Revenue | +16.6% | +4.8% | +3.4% | +21.0% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.7% | +2.7% | +21.8% | -2.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -10.0% | -35.0% | +82.9% | +4.0% | +28.2% |
Valuation Metrics
SWK leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 19.5x trailing earnings, SNA trades at a 44% valuation discount to EMR's 35.0x P/E. Adjusting for growth (PEG ratio), EPAC offers better value at 0.12x vs EMR's 7.74x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.9B | $12.6B | $2.8B | $19.5B | $79.1B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $18.2B | $3.3B | $19.2B | $91.4B |
| Trailing P/EPrice ÷ TTM EPS | 20.89x | 30.59x | 30.08x | 19.49x | 34.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.74x | 17.83x | 11.25x | 19.57x | 21.70x |
| PEG RatioP/E ÷ EPS growth rate | 0.12x | — | — | 1.79x | 7.74x |
| EV / EBITDAEnterprise value multiple | 12.59x | 11.80x | 11.64x | 13.44x | 18.09x |
| Price / SalesMarket cap ÷ Revenue | 3.04x | 0.83x | 1.40x | 3.78x | 4.39x |
| Price / BookPrice ÷ Book value/share | 4.46x | 1.36x | 2.12x | 3.33x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 20.39x | 18.32x | 23.05x | 19.36x | 29.67x |
Profitability & Efficiency
Evenly matched — EPAC and SNA each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
EPAC delivers a 20.9% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $4 for SWK. SNA carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs SNA's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.9% | +4.1% | +10.1% | +17.4% | +12.1% |
| ROA (TTM)Return on assets | +11.0% | +1.7% | +5.3% | +12.2% | +5.8% |
| ROICReturn on invested capital | +21.7% | +5.8% | +5.9% | +18.1% | +8.2% |
| ROCEReturn on capital employed | +20.8% | +7.0% | +6.8% | +18.4% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.53x | 0.65x | 0.49x | 0.22x | 0.68x |
| Net DebtTotal debt minus cash | $76M | $5.6B | $503M | -$298M | $12.2B |
| Cash & Equiv.Liquid assets | $152M | $280M | $141M | $1.6B | $1.5B |
| Total DebtShort + long-term debt | $228M | $5.9B | $643M | $1.3B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 13.59x | 2.07x | 5.27x | 27.12x | 6.46x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SNA five years ago would be worth $16,036 today (with dividends reinvested), compared to $4,402 for SWK. Over the past 12 months, KMT leads with a +77.9% total return vs EPAC's -17.7%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.8% vs SWK's 2.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.2% | +7.1% | +25.2% | +7.3% | +4.4% |
| 1-Year ReturnPast 12 months | -17.7% | +36.4% | +77.9% | +20.9% | +27.7% |
| 3-Year ReturnCumulative with dividends | +50.6% | +7.9% | +43.0% | +53.2% | +76.2% |
| 5-Year ReturnCumulative with dividends | +28.4% | -56.0% | -2.7% | +60.4% | +59.1% |
| 10-Year ReturnCumulative with dividends | +40.2% | -0.7% | +96.1% | +168.1% | +207.0% |
| CAGR (3Y)Annualised 3-year return | +14.6% | +2.6% | +12.7% | +15.3% | +20.8% |
Risk & Volatility
SNA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SNA is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than SWK's 1.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNA currently trades 93.3% from its 52-week high vs EPAC's 76.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 1.83x | 1.36x | 0.76x | 1.57x |
| 52-Week HighHighest price in past year | $46.39 | $93.37 | $43.81 | $400.88 | $165.15 |
| 52-Week LowLowest price in past year | $33.66 | $59.54 | $17.62 | $301.82 | $109.53 |
| % of 52W HighCurrent price vs 52-week peak | +76.6% | +86.8% | +82.4% | +93.3% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 48.6 | 59.0 | 60.9 | 46.1 | 51.4 |
| Avg Volume (50D)Average daily shares traded | 374K | 2.0M | 1.3M | 367K | 2.8M |
Analyst Outlook
Evenly matched — SWK and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EPAC as "Hold", SWK as "Hold", KMT as "Hold", SNA as "Buy", EMR as "Buy". Consensus price targets imply 14.2% upside for EMR (target: $161) vs 3.9% for KMT (target: $38). For income investors, SWK offers the higher dividend yield at 4.06% vs EPAC's 0.11%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $37.00 | $89.17 | $37.50 | $413.00 | $161.31 |
| # AnalystsCovering analysts | 19 | 37 | 23 | 17 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +4.1% | +2.2% | +2.3% | +1.5% |
| Dividend StreakConsecutive years of raises | 1 | 16 | 2 | 16 | 37 |
| Dividend / ShareAnnual DPS | $0.04 | $3.29 | $0.79 | $8.72 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +0.1% | +2.2% | +1.7% | +1.6% |
SNA leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). SWK leads in 1 (Valuation Metrics). 2 tied.
EPAC vs SWK vs KMT vs SNA vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EPAC or SWK or KMT or SNA or EMR a better buy right now?
For growth investors, Enerpac Tool Group Corp.
(EPAC) is the stronger pick with 4. 6% revenue growth year-over-year, versus -3. 9% for Kennametal Inc. (KMT). Snap-on Incorporated (SNA) offers the better valuation at 19. 5x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Snap-on Incorporated (SNA) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EPAC or SWK or KMT or SNA or EMR?
On trailing P/E, Snap-on Incorporated (SNA) is the cheapest at 19.
5x versus Emerson Electric Co. at 35. 0x. On forward P/E, Kennametal Inc. is actually cheaper at 11. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Enerpac Tool Group Corp. wins at 0. 11x versus Emerson Electric Co. 's 4. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EPAC or SWK or KMT or SNA or EMR?
Over the past 5 years, Snap-on Incorporated (SNA) delivered a total return of +60.
4%, compared to -56. 0% for Stanley Black & Decker, Inc. (SWK). Over 10 years, the gap is even starker: EMR returned +207. 0% versus SWK's -0. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EPAC or SWK or KMT or SNA or EMR?
By beta (market sensitivity over 5 years), Snap-on Incorporated (SNA) is the lower-risk stock at 0.
76β versus Stanley Black & Decker, Inc. 's 1. 83β — meaning SWK is approximately 143% more volatile than SNA relative to the S&P 500. On balance sheet safety, Snap-on Incorporated (SNA) carries a lower debt/equity ratio of 22% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — EPAC or SWK or KMT or SNA or EMR?
By revenue growth (latest reported year), Enerpac Tool Group Corp.
(EPAC) is pulling ahead at 4. 6% versus -3. 9% for Kennametal Inc. (KMT). On earnings-per-share growth, the picture is similar: Stanley Black & Decker, Inc. grew EPS 35. 9% year-over-year, compared to -12. 4% for Kennametal Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EPAC or SWK or KMT or SNA or EMR?
Snap-on Incorporated (SNA) is the more profitable company, earning 19.
7% net margin versus 2. 7% for Stanley Black & Decker, Inc. — meaning it keeps 19. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNA leads at 25. 8% versus 7. 3% for KMT. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EPAC or SWK or KMT or SNA or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Enerpac Tool Group Corp. (EPAC) is the more undervalued stock at a PEG of 0. 11x versus Emerson Electric Co. 's 4. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Kennametal Inc. (KMT) trades at 11. 2x forward P/E versus 21. 7x for Emerson Electric Co. — 10. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 2% to $161. 31.
08Which pays a better dividend — EPAC or SWK or KMT or SNA or EMR?
All stocks in this comparison pay dividends.
Stanley Black & Decker, Inc. (SWK) offers the highest yield at 4. 1%, versus 0. 1% for Enerpac Tool Group Corp. (EPAC).
09Is EPAC or SWK or KMT or SNA or EMR better for a retirement portfolio?
For long-horizon retirement investors, Snap-on Incorporated (SNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
76), 2. 3% yield, +168. 1% 10Y return). Stanley Black & Decker, Inc. (SWK) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SNA: +168. 1%, SWK: -0. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EPAC and SWK and KMT and SNA and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EPAC is a small-cap quality compounder stock; SWK is a mid-cap income-oriented stock; KMT is a small-cap quality compounder stock; SNA is a mid-cap quality compounder stock; EMR is a mid-cap quality compounder stock. SWK, KMT, SNA, EMR pay a dividend while EPAC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.